• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Polypeptide N-acetylgalactosaminyltransferase-like 6 (GALNTL6), Truncated

ACP17470

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP17470 Target NameGALNTL6
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Protein LengthPartialPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ49A17
Background Information
  • Uniprot Id

    Q49A17

  • Target Species

    Human

  • Target Name

    GALNTL6

  • Target Full Name

    Polypeptide N-acetylgalactosaminyltransferase-like 6

  • Target Function

    Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor.

  • Target Subcellular Location

    Golgi apparatus membrane; Single-pass type II membrane protein.

  • Target Protein Families

    Glycosyltransferase 2 family, GalNAc-T subfamily

  • Target Research Area

    Signal Transduction

  • Target Synonyms

    GALNTL6; GALNT17Polypeptide N-acetylgalactosaminyltransferase-like 6; EC 2.4.1.41; Polypeptide GalNAc transferase 17; GalNAc-T17; pp-GaNTase 17; Protein-UDP acetylgalactosaminyltransferase 17; Putative polypeptide N-acetylgalactosaminyltransferase 17; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 17

Inquire Recombinant Human Polypeptide N-acetylgalactosaminyltransferase-like 6 (GALNTL6), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification